Feedback / Questions
ALETA-001 - Aleta Biotherap
https://www.businesswire.com/news/home/20240221259676/en/Aleta-Biotherapeutics-and-Cancer-Research-UK%E2%80%99s-Centre-for-Drug-Development-Announce-First-Patient-Dosed-in-ALETA-001-Phase-12-Clinical-Trial-in-Patients-with-RelapsedRefractory-B-Cell-Malignancies
Feb 21, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next